Farhat, Rawad <br/><br/>
Carvedilol prevents counterregulatory failure and impaired hypoglycaemia awareness in non-diabetic recurrently hypoglycaemic rats.  [electronic resource] 

 -  Diabetologia  04 2019 
 - 676-686 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0428 
<br/><br/><label>Standard No.: </label>10.1007/s00125-018-4802-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-1 Receptor Antagonists--pharmacology<br/>Animals<br/>Blood Glucose<br/>Body Weight<br/>Carvedilol--therapeutic use<br/>Catheterization<br/>Deoxyglucose--administration & dosage<br/>Disease Models, Animal<br/>Glucose Clamp Technique<br/>Hyperglycemia--drug therapy<br/>Hypoglycemia--drug therapy<br/>Hypoglycemic Agents--adverse effects<br/>Insulin--adverse effects<br/>Lactic Acid--blood<br/>Male<br/>Rats<br/>Rats, Sprague-Dawley<br/>Recurrence<br/>Time Factors<br/>Ventromedial Hypothalamic Nucleus--drug effects